LLY

724.64

-0.01%↓

JNJ

181.13

+0.83%↑

ABBV

221.21

+0.22%↑

UNH

344.46

+0.09%↑

NVO

55.48

-0.22%↓

LLY

724.64

-0.01%↓

JNJ

181.13

+0.83%↑

ABBV

221.21

+0.22%↑

UNH

344.46

+0.09%↑

NVO

55.48

-0.22%↓

LLY

724.64

-0.01%↓

JNJ

181.13

+0.83%↑

ABBV

221.21

+0.22%↑

UNH

344.46

+0.09%↑

NVO

55.48

-0.22%↓

LLY

724.64

-0.01%↓

JNJ

181.13

+0.83%↑

ABBV

221.21

+0.22%↑

UNH

344.46

+0.09%↑

NVO

55.48

-0.22%↓

LLY

724.64

-0.01%↓

JNJ

181.13

+0.83%↑

ABBV

221.21

+0.22%↑

UNH

344.46

+0.09%↑

NVO

55.48

-0.22%↓

Search

Savara Inc

Abierto

SectorSanidad

3.51

Resumen

Variación precio

24h

Actual

Mínimo

3.46

Máximo

3.58

Métricas clave

By Trading Economics

Ingresos

-3.8M

-30M

Margen de beneficios

-10,677.941

Empleados

59

EBITDA

-1.9M

-30M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+150.85% upside

Dividendos

By Dow Jones

Próximas Ganancias

11 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

137M

603M

Apertura anterior

3.51

Cierre anterior

3.51

Noticias sobre sentimiento de mercado

By Acuity

83%

17%

347 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

Savara Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

26 sept 2025, 18:25 UTC

Principales Movimientos del Mercado

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

28 sept 2025, 23:48 UTC

Charlas de Mercado

Nikkei May Rise After Friday's Stock Gains on Wall Street -- Market Talk

28 sept 2025, 23:48 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 sept 2025, 23:45 UTC

Charlas de Mercado

Gold Rises Amid Fed Rate-Cut Hopes -- Market Talk

28 sept 2025, 23:34 UTC

Charlas de Mercado

Oil Falls on Likely Technical Correction -- Market Talk

27 sept 2025, 04:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

26 sept 2025, 21:56 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26 sept 2025, 20:54 UTC

Ganancias

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26 sept 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

26 sept 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

26 sept 2025, 20:27 UTC

Adquisiciones, fusiones, absorciones

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 sept 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

26 sept 2025, 19:54 UTC

Charlas de Mercado

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26 sept 2025, 19:53 UTC

Adquisiciones, fusiones, absorciones

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 sept 2025, 19:40 UTC

Ganancias

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26 sept 2025, 19:24 UTC

Charlas de Mercado

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26 sept 2025, 19:17 UTC

Charlas de Mercado

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26 sept 2025, 19:15 UTC

Charlas de Mercado

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26 sept 2025, 19:03 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

26 sept 2025, 19:03 UTC

Charlas de Mercado

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26 sept 2025, 18:50 UTC

Charlas de Mercado
Ganancias

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26 sept 2025, 18:36 UTC

Charlas de Mercado

Silver Closes Out Week With Strong Surge -- Market Talk

26 sept 2025, 18:02 UTC

Adquisiciones, fusiones, absorciones

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26 sept 2025, 18:02 UTC

Adquisiciones, fusiones, absorciones

ING: Global Development Hasn't Received All Necessary Approvals >ING

26 sept 2025, 18:02 UTC

Adquisiciones, fusiones, absorciones

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26 sept 2025, 17:54 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26 sept 2025, 16:56 UTC

Charlas de Mercado
Ganancias

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26 sept 2025, 16:41 UTC

Charlas de Mercado
Ganancias

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26 sept 2025, 16:26 UTC

Ganancias

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26 sept 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Savara Inc previsión

Precio Objetivo

By TipRanks

150.85% repunte

Estimación a 12 Meses

Media 8.83 USD  150.85%

Máximo 16 USD

Mínimo 2 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Savara Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

2.76 / 2.84Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

347 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.
help-icon Live chat